Nymox Pharmaceutical
NYMX
#9952
Rank
C$26.42 M
Marketcap
Country
$0.29
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -C$2.91 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$9.45 Million, an increase over its 2021 earnings that were of -C$18.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$2.91 Million-69.24%
2022 -C$9.45 Million-47.71%
2021 -C$18.07 Million6.61%
2020 -C$16.95 Million-10.91%
2019 -C$19.03 Million24.24%
2018 -C$15.32 Million-20.03%
2017 -C$19.15 Million2.71%
2016 -C$18.65 Million-63.86%
2015 -C$51.59 Million674.44%
2014 -C$6.67 Million-6.11%
2013 -C$7.1 Million-35.66%
2012 -C$11.03 Million-20.76%
2011 -C$13.92 Million38.33%
2010 -C$10.07 Million35.59%
2009 -C$7.43 Million11.8%
2008 -C$6.64 Million-12.94%
2007 -C$7.63 Million8.85%
2006 -C$7.01 Million36.5%
2005 -C$5.14 Million-4.4%
2004 -C$5.37 Million-14.58%
2003 -C$6.29 Million
2001 -C$4.61 Million-20.54%
2000 -C$5.81 Million21.72%
1999 -C$4.77 Million-25.56%
1998 -C$6.41 Million101.3%
1997 -C$3.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$9.81 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.05 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.61 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.69 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$26.63 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA